CYBB and obesity disorder: Regarding Nox2 mRNA level, the interaction of two main factors - obesity and QCT therapy (p < 0.05) was detected, where administration of QCT decreased Nox2 expression in the group of obese rats, but not in lean animals (Fig. 9A).